Project Grant R56AG084128
Award Date
9/15/23
Completion Date
8/31/24
Dollars Obligated
$871K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
This federal Project Grant award of $614,424 from the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of Washington aims to investigate the role of microglia, the brain's immune cells, in the early progression of Alzheimer's disease (AD). The key products and services to be delivered under this 2-year award include: Applying novel explainable AI techniques and deep learning methods to single-cell brain data to better define subtle microglial changes and AD-specific...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $442,357 in funding to the Research Foundation of the City University of New York (RFCUNY) for research to elucidate molecular mechanisms underlying the neurodegenerative reprogramming of microglia in Alzheimer's disease. The key objectives are to determine how the integrated stress response pathway triggers chromatin remodeling in microglia, examine how this exacerbates their stressed...
This $427,625 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to elucidate the mechanisms by which microgliopathy, a genetic neurological disorder, causes early-onset dementia. The research will investigate how the loss of the DAP12 protein in microglia, the immune cells of the brain, leads to heightened signaling of the RUNX and STAT3 pathways. This dysregulation is hypothesized to disrupt normal microglial functions and induce brain pathology and...
This $205,619 Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) supports research to map the landscape of the aged human brain and model neurodegenerative diseases like Alzheimer's. The University of Washington will apply explainable AI methods to human brain datasets to identify molecular drivers of brain aging, then manipulate these drivers in human induced pluripotent stem cell (iPSC) models to generate aging phenotypes in neurons and glia. This two-phase...
This Project Grant award, funded by the National Institute on Aging (CFDA 93.866 - Aging Research), supports research to identify microglial subpopulations that may contribute to resilience against Alzheimer's disease (AD) pathology. The $188,892 award to the University of Washington will enable the Principal Investigator, Dr. Prater, to evaluate microglial subpopulations in both human resilient individuals and a mouse model of AD resilience using single-nucleus RNA sequencing. The project...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to investigate the cell-type specific impacts of Alzheimer's disease (AD) pathology within the medial temporal lobe. The $103,304 award, effective August 1, 2024 through July 31, 2025, will utilize advanced viral tracing methods and microscopy imaging to identify and reconstruct 3D entorhinal cortex-CA1 neuron circuits that are susceptible to AD pathology propagation. After...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $433,125 will fund a study to investigate the relationship between microglia, neurons, and tau pathology in Alzheimer's disease. The research will utilize a novel model system of microglial co-cultures with hippocampal assembloids derived from patient-derived induced pluripotent stem cell (iPSC) lines with MAPT mutations and healthy controls. The goal is to explore how bidirectional changes...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) supports research to investigate the role of pathogen-induced cellular senescence and blood-brain barrier dysfunction in the development and progression of Alzheimer's disease. The $794,341 award, effective from January 1, 2025 through December 31, 2029, will be conducted by the University of Illinois in Chicago. The research aims to leverage experimental mouse models, molecular characterization of...
This $745,765 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the Icahn School of Medicine at Mount Sinai (ISMMS) in New York aims to investigate the effects of Alzheimer's disease (AD) risk genes and aging on human microglia activity and lipid metabolism. The key focus is on understanding how genetic variants associated with increased AD risk or longevity may impact microglia's ability to clear cholesterol/lipid-rich cellular debris, a critical...
This $343,440 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports a research study by Dr. Lolita Nidadavolu at the Johns Hopkins University School of Medicine. The study aims to examine the association between cell-free DNA and microglial activation in Alzheimer's disease. Specifically, the project will analyze serum samples to assess the relationship between cell-free DNA levels and microglial activation markers (Aim 1). It will also...